Four Republicans Don’t Support Senate Bill
Senators Ted Cruz (R-Texas), Rand Paul (R-Kentucky), Ron Johnson (R-Wisconsin), and Mike Lee (R-Utah) came out almost immediately against the Senate healthcare bill when it was released on Thursday. According to The Washington Post, the 4 senators said they cannot support the current bill. Cruz, Paul, and Lee want the bill to go further to repeal the Affordable Care Act (ACA), while Johnson wants more time before voting on the bill—currently, Senate Majority Leader Mitch McConnell (R-Kentucky) wants to vote on the bill next week, before senators go home for the Fourth of July recess.
Opioid Funding in Senate Healthcare Bill
The Senate healthcare bill does not just rollback pieces of the ACA and reform Medicaid, it also includes funding for opioid addiction treatment. While some Republican senators had been looking to get $45 billion in funding over 10 years, the bill only includes $2 billion for 1 year, reported The Wall Street Journal. Reactions were mixed with Senator Lamar Alexander (R-Tennessee) approving of the funding while Senators Rob Portman (R-Ohio) and Shelley Moore Capito (R-West Virginia) likely to push for more funding during negotiations.
Humana Is Done With Individual Market
Humana’s CEO said that the insurer is done with the individual insurance market. Regardless of whether Republicans reshape the market through a bill repealing the ACA or if Obamacare stays the law of the land and stabilizes, Humana has no plans to reenter the individual market, according to Reuters. In February, the insurer announced it was leaving the market in 11 states—instead it will focus on Medicare Advantage, according to its CEO.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More